The Journal of Experimental Medicine
Rockland Immunochemicals for Research
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online December 4, 2006
doi:10.1084/jem.20061519
The Journal of Experimental Medicine, Vol. 203, No. 13, 2887-2893
The Rockefeller University Press, 0022-1007 $30.00
© 2006 Pion et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2013K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pion, M.
Right arrow Articles by Piguet, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pion, M.
Right arrow Articles by Piguet, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

 APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection

Marjorie Pion1,2, Angela Granelli-Piperno3,4, Bastien Mangeat1,2, Romaine Stalder1,2, Rafael Correa1,2, Ralph M. Steinman3,4, and Vincent Piguet1,2

1 Department of Dermatology and Venereology and 2 Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
3 Laboratory of Cellular Physiology and Immunology and 4 Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10021

CORRESPONDENCE Vincent Piguet: vincent.piguet{at}medecine.unige.ch

HIV-1 infects immature dendritic cells (iDCs), but infection is inefficient compared with activated CD4+ T cells and only involves a small subset of iDCs. We analyzed whether this could be attributed to specific cellular restrictions during the viral life cycle. To study env-independent restriction to HIV-1 infection, we used a single-round infection assay with HIV-1 pseudotyped with vesicular stomatitis virus G protein (HIV-VSVG). Small interfering RNA–mediated depletion of APOBEC3G/3F (A3G/3F), but not TRIM5{alpha}, enhanced HIV-1 infection of iDCs, indicating that A3G/3F controls the sensitivity of iDCs to HIV-1 infection. Furthermore, sequences of HIV reverse transcripts revealed G-to-A hypermutation of HIV genomes during iDC infection, demonstrating A3G/3F cytidine deaminase activity in iDCs. When we separated the fraction of iDCs that was susceptible to HIV, we found the cells to be deficient in A3G messenger RNA and protein. We also noted that during DC maturation, which further reduces susceptibility to infection, A3G levels increased. These findings highlight a role for A3G/3F in explaining the resistance of most DCs to HIV-1 infection, as well as the susceptibility of a fraction of iDCs. An increase in the A3G/3F-mediated intrinsic resistance of iDCs could result in a block of HIV infection at its mucosal point of entry.

Abbreviations used: A3F and A3G, APOBEC3F and APOBEC3G, respectively; iDC, immature DC; JT, Jurkat CD4+ T cell; LMM, low molecular mass; LV, lentiviral vector; mDC, monocyte-derived DC; MOI, multiplicity of infection; mRNA, messenger RNA; P, pellet; siRNA, small interfering RNA; SN, supernatant; T5{alpha}, Trim5{alpha}; VSVG, vesicular stomatitis virus G.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS